The revenue stands at ₹4,516.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.23 per cent from ₹4,173.00 crore. This corresponds to a year-on-year *(YoY) growth of 2.25 per cent.
Operating Profit stands at ₹939.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 74.02 per cent from ₹540.10 crore. This corresponds to a year-on-year *(YoY) decline of 12.83 per cent.
PBDT stands at ₹760.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 70.03 per cent from ₹447.50 crore. This corresponds to a year-on-year *(YoY) decline of 17.57 per cent.
Profit Before Tax stands at ₹247.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 465.04 per cent from ₹-67.80 crore. This corresponds to a year-on-year *(YoY) decline of 49.16 per cent.
Net Profit stands at ₹198.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 483.40 per cent from ₹-51.80 crore. This represents a 56.77 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Biocon | -0.09% | -0.72% | 18.81% | 10.29% | 7.58% | 28.16% |
| Mankind Pharma | -0.77% | -4.72% | 8.63% | 9.51% | 9.45% | 0.31% |
| Aurobindo Pharma | -0.76% | -4.25% | 2.53% | 18.98% | 17.57% | 22.04% |
| Laurus Labs | 1.07% | -0.26% | 20.81% | 26.33% | 35.17% | 125.63% |
| Glenmark Pharma. | 3.38% | -1.77% | 0.46% | 9.26% | 20.21% | 68.75% |
| Alkem Lab | -0.10% | -0.71% | 0.97% | -4.23% | -5.14% | 2.68% |
| Abbott India | -0.37% | 0.99% | 8.91% | 4.62% | -5.88% | -8.93% |
Chairperson : Kiran Mazumdar Shaw
Non Executive Director : Ravi Mazumdar
Independent Director : Bobby Parikh
Non Executive Director : Eric Vivek Mazumdar
Lead Independent Director : Naina Lal Kidwai
Independent Director : Atul Dhawan
Independent Director : Rekha Mehrotra Menon
Independent Director : NICHOLAS ROBERT HAGGAR
Company Sec. & Compli. Officer : Ekta Agarwal
Managing Director & Chief Executive Officer : Shreehas Pradeep Tambe